small cell lung cancer prognosis stage 2
Báo cáo hóa học: " Detection of EGFR mutations with mutation-specific antibodies in stage IV non-small-cell lung cancer" pdf
Ngày tải lên :
18/06/2014, 16:20
... 69 61 57 21 7 60
SCC 1 0 7 1 12 0
LCC 5 0 4 11 0
others 3 0 2 0 0
EGFR
exon 19 29 10 18 21 55 58 21
exon21 27 0 12 14 18 56 23
wild-type 22 51 29 29 6 145 167 16
IHC sensitivity
overall 92%
delE746-A750 ... non -small- cell lung cancer. Clin Cancer Res 20 09,
15:3 023 -3 028 .
13. Motoi N, Szoke J, Riely GJ, Seshan VE, Kris MG, Rusch VW, Gerald WL,
Travis WD: Lung adenocarcinoma: modification of the 20 04 ... anticancer agents. Nat Rev Cancer
20 10, 10 :24 1 -25 3.
2. Sharma SV, Bell DW, Settleman J, Haber DA: Epidermal growth factor
receptor mutations in lung cancer. Nat Rev Cancer 20 07, 7:169-181.
3. Kosaka...
- 8
- 798
- 0
Báo cáo khoa học: "Clinical outcomes of stereotactic body radiotherapy for stage I non-small cell lung cancer using different doses depending on tumor size" ppsx
Ngày tải lên :
09/08/2014, 09:20
... non -small- cell lung
cancer. Int J Radiat Oncol Biol Phys 20 02, 52: 3 82- 389.
16. Qiao X, Tullgren O, Lax I, Sirzén F, Lewensohn R: The role of radiotherapy
in treatment of stage I non -small cell lung ... phase II trial of medically inoperable stage I non -small- cell
lung cancer patients treated with stereotactic body radiotherapy. J Clin
Oncol 20 09, 27 : 329 0- 329 6.
6. Takeda A, Sanuki N, Kunieda E, ... size (mm)
Range (median) 12- 55 (27 ) 12, 14 15-34 (24 ) 31-55 (35)
Operability
Operable 40 2 27 11
Non-operable 84 0 58 26
Histology
Adenocarcinoma 66 2 46 18
Squamous cell carcinoma 35 0 19 16
Unclassified...
- 7
- 297
- 0
Báo cáo khoa học: "The effect of bioequivalent radiation dose on survival of patients with limited-stage small-cell lung cancer" pdf
Ngày tải lên :
09/08/2014, 09:20
... 106(78.5)
LDH 0.517
22 0 IU/L 35(43.1) 34(35.3)
> ;22 0 IU/L 25 (26 .4) 78 (22 .6)
Unknown 10(30.5) 23 ( 42. 1)
ISN 0.190
Yes 8(11.4) 25 (18.5)
No 62( 88.6) 110(81.5)
CHT cycles 0. 620
Median 4 6
Range ... in lung cancer: small- cell lung
cancer (SCLC). Int J Radiat Oncol Biol Phys 20 08, 72: 327 -334.
33. Roof KS, Fidias P, Lynch TJ, Choi NC: Radiation dose intensification in
limited -stage small- cell ... limited -stage small cell lung cancer. [http://
clinicaltrials.gov/ct2/show/NCT00433563].
27 . Three different radiation therapy regimens in treating patients with
limited -stage small cell lung cancer...
- 9
- 465
- 0
Báo cáo khoa học: " Comparison of outcomes in patients with stage III versus limited stage IV non-small cell lung cancer" docx
Ngày tải lên :
09/08/2014, 09:20
... Non -Small Cell Lung Cancer
Background
Non -small cell lung cancer (NSCLC) is the leading
cause of cancer mortality in the United States [1].
Patients with stage IV NSCLC typically have a poor
prognosis, ... April 20 11 Accepted: 30 June 20 11 Published: 30 June 20 11
References
1. Jemal A, Siegel R, Xu J, Ward E: Cancer Statistics, 20 10. CA Cancer J Clin
20 10, 60(5) :27 7-300, Epub 20 10 Jul 7.
2. Greene ... Oncology 20 11, 6:80
http://www.ro-journal.com/content/6/1/80
Page 2 of 7
RESEARC H Open Access
Comparison of outcomes in patients with stage III
versus limited stage IV non -small cell lung cancer
Praveena...
- 7
- 368
- 0
Báo cáo khoa học: "Recommendations for implementing stereotactic radiotherapy in peripheral stage IA non-small cell lung cancer: report from the Quality Assurance Working Party of the randomised phase III ROSEL study" pps
Ngày tải lên :
09/08/2014, 09:22
... > 18 to 22 25 > 25 to 28
Oesophagus 1 24 > 24 to 27 27 > 27 to 28 .5
Ipsilateral Brachial Plexus 1 24 > 24 to 26 27 > 27 to 29
Heart 1 24 > 24 to 26 27 > 27 to 29
Trachea ... body radiotherapy for stage I
non -small cell lung cancer. Radiother Oncol 20 07, 85: 429 -434.
39. Sinha B, McGarry RC: Stereotactic body radiotherapy for bilat-
eral primary lung cancers: the Indiana ... and 108 cc)Figure 5
Percent of lung (both lungs minus GTV) receiving 20 Gy or more (V
20 Gy
) from a total of 22 patients with stage
I tumours and 4 patients with stage 1B tumours (with PTVs of...
- 14
- 308
- 0
báo cáo hóa học:" Randomized phase II study with two gemcitabine- and docetaxel-based combinations as first-line chemotherapy for metastatic non-small cell lung cancer" docx
Ngày tải lên :
18/06/2014, 15:20
... (OS) (B).
0 4 8 121 620 2 428 323 6404448 52
Weeks
0
0 .2
0.4
0.6
0.8
1
TTP
Patients Events (%)
Arm A 35 33 (94.3)
Arm B 34 32 (94.1)
A
0 4 8 12 16 20 24 28 32 36 40 44 48 52
Weeks
0
0 .2
0.4
0.6
0.8
1
Survival
Patients ... Estimating the world cancer
burden: Globocan 20 00. Int J Cancer 20 01, 94:153-156.
2. Non -small Cell Lung Cancer Collaborative Group: Chemotherapy
in non small cell lung cancer: a meta-analysis ... chemotherapy in
patients with advanced non -small cell lung cancer: a lung
cancer Galician group phase II study. Cancer Chemother Pharma-
col 20 07, 60: 725 -7 32.
20 . Binder D, Sailer V, Schweigert M,...
- 8
- 538
- 0
Báo cáo hóa học: "Involvement of aryl hydrocarbon receptor signaling in the development of small cell lung cancer induced by HPV E6/E7 oncoproteins" ppt
Ngày tải lên :
18/06/2014, 16:20
... risk marker of lung cancer in Taiwan. Cancer 20 03,
97:1558-1563.
11. Klein F, Amin Kotb WF, Petersen I: Incidence of human papilloma virus in
lung cancer. Lung Cancer 20 09, 65:13-18.
12. Zochbauer-Muller ... are often divided
into two broad categories: small cell lung cancer (SCLC) and non -small cell lung cancer (NSCLC). All major
histological types of lung cancer are associated with smoking, although ... liver
carcinogenesis. Cancer Res 20 10, 70 :21 2 -22 0.
34. Puga A, Xia Y, Elferink C: Role of the aryl hydrocarbon receptor in cell
cycle regulation. Chem Biol Interact 20 02, 141:117-130.
35. Chang...
- 11
- 471
- 0
Báo cáo hóa học: "Prognostic Impact of MiR-155 in Non-Small Cell Lung Cancer Evaluated by in Situ Hybridization" pot
Ngày tải lên :
18/06/2014, 16:20
... with
bevacizumab for non -small- cell lung cancer. N Engl J Med 20 06,
355 :25 42- 50.
21 . Besse B, Ropert S, Soria JC: Targeted therapies in lung cancer. Ann Oncol
20 07, 18(Suppl 9):ix135-ix1 42.
22 . Scagliotti ... Wedge* 24 3 73 190 61
Pneumonectomy 92 27 37 47
Pathological stage <0.001
I 157 47 190 71
II 136 41 61 51
IIIa 42 12 17 23
Tumor status <0.001
1 85 25 190 74
2 188 56 84 57
3 621 925 36
Nodal ... status <0.001
0 23 2 69 190 66
17 623 3543
2 27 8 18 18
Surgical margins 0 .29
Free 307 92 190 58
Not free 28 8 47 47
Vascular infiltration <0.001
No 28 4 85 190 58
Yes 51 15 27 32
NR, not reached.
*...
- 9
- 662
- 0
báo cáo hóa học: " Health state utilities for non small cell lung cancer" pot
Ngày tải lên :
18/06/2014, 19:20
... A, Ward E, Thun MJ: Cancer
statistics, 20 03. CA Cancer J Clin 20 03, 53:5 -26 .
5. Busick NP, Fretz PC, Galvin JR, Peterson MW: Staging of small cell
and non -small cell lung cancer. University of ... NSCLC.
Background
In 20 02, approximately 29 ,000 people died from lung
cancer in England and Wales[1] and it is the most com-
mon and the most life-threatening form of cancer in Scot-
land [2] . Lung cancer ... Lilenbaum R: Chemothera-
peutic management of stage IV non -small cell lung cancer.
Chest 20 03, 123 :22 65-435.
Health and Quality of Life Outcomes 20 08, 6:84 http://www.hqlo.com/content/6/1/84
Page 7...
- 15
- 397
- 0
Báo cáo toán học: "Molecular Predictors of EGFR-TKI Sensitivity in Advanced Non–small Cell Lung Cancer" ppsx
Ngày tải lên :
08/08/2014, 17:20
... Biol. 20 01; 2( 2): 127 -37.
11. Scagliotti GV, Selvaggi G, Novello S, et al. The biology of epi-
dermal growth factor receptor in lung cancer. Clin Cancer Res.
20 04; 10( 12 Pt 2) : 422 7s-32s.
12. ...
advanced non -small- cell lung cancer previously treated with
platinum-containing chemotherapy regimens. The TAX 320
Non -Small Cell Lung Cancer Study Group. J Clin Oncol. 20 00;
18( 12) : 23 54- 62.
7. ... gefitinib in non -small cell lung cancer
cell lines. Mol Cancer Res. 20 06; 4(8): 521 -8.
1 02. Taguchi F, Solomon B, Gregorc V, et al. Mass spectrometry to
classify non -small- cell lung cancer patients...
- 9
- 203
- 0
Báo cáo khoa học: "Pathological complete response induced by first-line chemotherapy with single agent docetaxel in a patient with advanced non small cell lung cancer" pptx
Ngày tải lên :
09/08/2014, 03:21
... agent
docetaxel in a patient with advanced non small
cell lung cancer
Ferdinando Riccardi
1*
, Giuseppe Di Lorenzo
1
, Carlo Buonerba
1
, Guglielmo Monaco
2
, Roberto Monaco
3
,
Mimma Rizzo
1
, Sarah ... treatment.
Introduction
In non -small cell lung cancer (NSCLC), mediastinal
lymphnode involvement comprises a wide spectrum of
severity. In fact, while 9% of patients with IIIA-N2
NSCLC is candidate for ... Carteni’
1
Abstract
Background: Defining the optimal treatment for patients with inoperable non small cell lung cancer (NSCLC),
presenting with metastatic mediastinal lymph nodes, is challenging. Nevertheless,...
- 4
- 303
- 0
Báo cáo khoa học: "Analysis of clinical and dosimetric factors associated with severe acute radiation pneumonitis in patients with locally advanced non-small cell lung cancer treated with concurrent chemotherapy and intensity-modulated radiotherapy" pot
Ngày tải lên :
09/08/2014, 08:23
... 7.09
0.0 02
V25 12. 96% (5.90 -26 .26 %)
= 12. 88, SD = 4. 42 = 20 .91, SD = 6.98
0.001
V30 10.00% (4.68 -21 .43%)
= 9. 72, SD = 3.45 = 15.69, SD = 6.00
0.008
V35 9. 92% (3.89-18.65%)
= 7.57, SD = 2. 86 = ... 11 .26 , SD = 2. 81 = 14.91, SD = 2. 91
0.001
NTCP 2. 33% (0.51-9.68%)
= 2. 51, SD = 1.73 = 5.94, SD = 2. 40
0.001
V5 58.73% ( 32. 89-97.65%)
= 58.43, SD = 16.57 = 69 .23 , SD = 12. 47
0.006
V10 42. 16% (25 .28 -83.34%)
... 42. 16% (25 .28 -83.34%)
= 41.13, SD = 12. 69 = 52. 42, SD = 11.05
0.001
V15 29 .53%(16.46-58.51%)
= 28 .94, SD = 9. 12 = 38.30, SD = 7.65
0.005
V20 18.15% (9.46-31.08%)
= 18.59, SD = 6.03 = 28 . 02, SD...
- 8
- 371
- 0
Báo cáo khoa học: " Exclusion of elective nodal irradiation is associated with minimal elective nodal failure in non-small cell lung cancer" potx
Ngày tải lên :
09/08/2014, 09:22
... (IAEA)
consultants' meeting on elective nodal irradiation in lung
cancer: non -small cell lung cancer (NSCLC). Int J Radiat Oncol
Biol Phys 20 08, 72( 2):335-3 42.
6. Therasse P, Arbuck SG, Eisenhauer EA, Wanders ... (37)
Squamous cell carcinoma 39 (34)
Large cell carcinoma 3 (3)
Mixed 2 (2)
Non -small cell not otherwise specified 28 (24 )
Grade (%)
Well-differentiated 7 (6)
Moderately differentiated 12 (10)
Poorly ... Clin Oncol 20 05, 28 :597-6 02.
15. Chang JY, Liu HH, Komaki R: Intensity modulated radiation
therapy and proton radiotherapy for non -small cell lung can-
cer. Curr Oncol Rep 20 05, 7 :25 5-9.
16....
- 7
- 375
- 0
Báo cáo khoa học: "Radiotherapy quality assurance review in a multi-center randomized trial of limited-disease small cell lung cancer: the Japan Clinical Oncology Group (JCOG) trial 0202" pptx
Ngày tải lên :
09/08/2014, 09:22
... JCOG 020 2 seemed to be acceptable,
providing reliable results.
Published: 2 June 20 09
Radiation Oncology 20 09, 4:16 doi:10.1186/1748-717X-4-16
Received: 20 February 20 09
Accepted: 2 June 20 09
This ... trial of limited-disease small cell lung cancer: the Japan
Clinical Oncology Group (JCOG) trial 020 2
Naoko Sanuki-Fujimoto
†1
, Satoshi Ishikura*
†1 ,2
, Kazushige Hayakawa
2
,
Kaoru Kubota
3
, ... periodically at least twice a month by the RT
Schema of JCOG 020 2Figure 1
Schema of JCOG 020 2. Abbreviations. LD-SCLC, limited-
disease small cell lung cancer; PS, performance status; EP,
etoposide; CDDP,...
- 5
- 293
- 0